{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T22:19:03Z","timestamp":1767910743106,"version":"3.49.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2010,10,14]],"date-time":"2010-10-14T00:00:00Z","timestamp":1287014400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Gastroenterol"],"published-print":{"date-parts":[[2010,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>S100A12, a calcium-binding proinflammatory protein secreted by granulocytes, has been associated with different diseases of inflammatory origin, including inflammatory bowel disease (IBD). In this study, the utility of serum S100A12, in discriminating IBD from irritable bowel syndrome (IBS), was tested.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>S100A12 serum levels were determined in 64 patients with ulcerative colitis (UC), 64 with Crohn's disease (CD) and 73 with IBS, by means of an enzyme-linked immunosorbent assay. S100A12 serum levels were evaluated with respect to the levels of known inflammatory markers and patients' characteristics.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>The median values of serum S100A12 levels were 68.2 ng\/mL (range: 43.4-147.4) in UC, 70 ng\/mL (41.4-169.8) in CD and 43.4 ng\/mL (34.4-74.4) in IBS patients. UC and CD patients had significantly higher serum S100A12 levels compared to IBS patients (<jats:italic>P<\/jats:italic>= 0.001 for both comparisons). Moreover, a cut-off for serum S100A12 levels of 54.4 ng\/mL could predict both UC and CD with a 66.7% sensitivity and a 64.4% specificity. The area under curve was estimated at 0.67 with a 95% confidence interval of 0.60-0.75 (<jats:italic>P<\/jats:italic>&lt; 0.001). Considering standard activity indices, higher serum S100A12 levels in active compared to inactive IBD were observed, although the recorded difference did not reach statistical significance. C-reactive protein (CRP) and serum amyloid A (SAA) levels, showed a statistically significant positive correlation with S100A12 (r = 0.39,<jats:italic>P<\/jats:italic>= 0.001 and r = 0.23,<jats:italic>P<\/jats:italic>= 0.02 respectively).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Increased levels of circulating S100A12 are found in IBD, compared to IBS. When used to distinguish IBD from IBS adult patients, serum S100A12 levels exhibit moderate performance. On the other hand, serum S100A12 may serve as an inflammatory marker in IBD, since it is well correlated with CRP and SAA.<\/jats:p><\/jats:sec>","DOI":"10.1186\/1471-230x-10-118","type":"journal-article","created":{"date-parts":[[2010,10,15]],"date-time":"2010-10-15T18:15:41Z","timestamp":1287166541000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":35,"title":["Moderate performance of serum S100A12, in distinguishing inflammatory bowel disease from irritable bowel syndrome"],"prefix":"10.1186","volume":"10","author":[{"given":"Anastassios C","family":"Manolakis","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andreas N","family":"Kapsoritakis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Panagiotis","family":"Georgoulias","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chara","family":"Tzavara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Varvara","family":"Valotassiou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anastasia","family":"Kapsoritaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Spyros P","family":"Potamianos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2010,10,14]]},"reference":[{"key":"508_CR1","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.cgh.2008.08.032","volume":"7","author":"M Grover","year":"2009","unstructured":"Grover M, Herfarth H, Drossman DA: The functional-organic dichotomy: postinfectious irritable bowel syndrome and inflammatory bowel disease irritable bowel syndrome. Clin Gastroenterol Hepatol. 2009, 7: 48-53.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"508_CR2","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1373\/clinchem.2005.058560","volume":"52","author":"X Bossuyt","year":"2006","unstructured":"Bossuyt X: Serologic markers in inflammatory bowel disease. Clin Chem. 2006, 52: 171-181.","journal-title":"Clin Chem"},{"key":"508_CR3","doi-asserted-by":"publisher","first-page":"3751","DOI":"10.1016\/j.cccn.2004.02.023","volume":"344","author":"D Foell","year":"2004","unstructured":"Foell D, Frosch M, Sorg C, Roth J: Phagocyte-specific calcium-binding S100 proteins as clinical laboratory markers of inflammation. Clin Chim Acta. 2004, 344: 3751-","journal-title":"Clin Chim Acta"},{"key":"508_CR4","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1189\/jlb.0306170","volume":"81","author":"D Foell","year":"2007","unstructured":"Foell D, Wittkowski H, Vogl T, Roth J: S100 proteins expressed in phagocytes: a novel group of damage-associated molecular pattern molecules. J Leukoc Biol. 2007, 81: 28-37.","journal-title":"J Leukoc Biol"},{"key":"508_CR5","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1042\/BJ20060195","volume":"396","author":"L Santamaria-Kisiel","year":"2006","unstructured":"Santamaria-Kisiel L, Rintala-Dempsey AC, Shaw GS: Calcium-dependent and -independent interactions of the S100 protein family. Biochem J. 2006, 396: 201-214.","journal-title":"Biochem J"},{"key":"508_CR6","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1097\/01.ibd.0000227626.72271.91","volume":"12","author":"NS de Jong","year":"2006","unstructured":"de Jong NS, Leach ST, Day AS: Fecal S100A12: a novel noninvasive marker in children with Crohn's disease. Inflamm Bowel Dis. 2006, 12: 566-572.","journal-title":"Inflamm Bowel Dis"},{"key":"508_CR7","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1002\/ibd.20336","volume":"14","author":"MA Sidler","year":"2008","unstructured":"Sidler MA, Leach ST, Day AS: Fecal S100A12 and fecal calprotectin as noninvasive markers for inflammatory bowel disease in children. Inflamm Bowel Dis. 2008, 14: 359-366.","journal-title":"Inflamm Bowel Dis"},{"key":"508_CR8","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1136\/gut.52.6.847","volume":"52","author":"D Foell","year":"2003","unstructured":"Foell D, Kucharzik T, Kraft M, Vogl T, Sorg C, Domschke W, Roth J: Neutrophil derived human S100A12 (EN-RAGE) is strongly expressed during chronic active inflammatory bowel disease. Gut. 2003, 52: 847-853.","journal-title":"Gut"},{"key":"508_CR9","doi-asserted-by":"publisher","first-page":"1706","DOI":"10.1136\/gut.2006.113431","volume":"56","author":"T Kaiser","year":"2007","unstructured":"Kaiser T, Langhorst J, Wittkowski H, Becker K, Friedrich AW, Rueffer A, Dobos GJ, Roth J, Foell D: Faecal S100A12 as a non-invasive marker distinguishing inflammatory bowel disease from irritable bowel syndrome. Gut. 2007, 56: 1706-1713.","journal-title":"Gut"},{"key":"508_CR10","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.1080\/00365520701416709","volume":"42","author":"ST Leach","year":"2007","unstructured":"Leach ST, Yang Z, Messina I, Song C, Geczy CL, Cunningham AM, Day AS: Serum and mucosal S100 proteins, calprotectin (S100A8\/S100A9) and S100A12, are elevated at diagnosis in children with inflammatory bowel disease. Scand J Gastroenterol. 2007, 42: 1321-1331.","journal-title":"Scand J Gastroenterol"},{"key":"508_CR11","first-page":"307","volume":"15","author":"Rome Foundation","year":"2006","unstructured":"Rome Foundation: Guidelines--Rome III Diagnostic Criteria for Functional Gastrointestestinal Disorders. J Gastrointestinal Liver Dis. 2006, 15: 307-312.","journal-title":"J Gastrointestinal Liver Dis"},{"key":"508_CR12","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/S0016-5085(76)80163-1","volume":"70","author":"WR Best","year":"1976","unstructured":"Best WR, Becktel JM, Singleton JW, Kern F: \"Development of a Crohn's disease activity index. National Cooperative Crohn's Disease Study\". Gastroenterology. 1976, 70: 439-444.","journal-title":"Gastroenterology"},{"key":"508_CR13","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1136\/bmj.298.6666.82","volume":"298","author":"D Rachmilewitz","year":"1989","unstructured":"Rachmilewitz D: Coated mesalazine (5-aminosalicylic acid) versus sulphasalazine in the treatment of active ulcerative colitis: a randomised trial. BMJ. 1989, 298: 82-86.","journal-title":"BMJ"},{"key":"508_CR14","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1097\/00054725-200002000-00002","volume":"6","author":"C Gasche","year":"2000","unstructured":"Gasche C, Scholmerich J, Brynskov J, D'Haens G, Hanauer SB, Irvine EJ, Jewell DP, Rachmilewitz D, Sachar DB, Sandborn WJ, Sutherland LR: A simple classification of Crohn's disease: report of the Working Party for the World Congresses of Gastroenterology, Vienna 1998. Inflamm Bowel Dis. 2000, 6: 8-15.","journal-title":"Inflamm Bowel Dis"},{"issue":"suppl A","key":"508_CR15","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1155\/2005\/269076","volume":"19","author":"MS Silverberg","year":"2005","unstructured":"Silverberg MS, Satsangi J, Ahmad T, Arnott ID, Bernstein CN, Brant SR, Caprilli R, Colombel JF, Gasche C, Geboes K, Jewell DP, Karban A, Loftus EV, Pe\u00f1a AS, Riddell RH, Sachar DB, Schreiber S, Steinhart AH, Targan SR, Vermeire S, Warren BF: Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: Report of a Working Party of the 2005 Montreal World Congress of Gastroenterology. Can J Gastroenterol. 2005, 19 (suppl A): 5-36.","journal-title":"Can J Gastroenterol"},{"key":"508_CR16","first-page":"90","volume":"44","author":"C Niederau","year":"1997","unstructured":"Niederau C, Backmerhoff F, Schumacher B, Niederau C: Inflammatory mediators and acute phase proteins in patients with Crohn's disease and ulcerative colitis. Hepatogastroenterology. 1997, 44: 90-107.","journal-title":"Hepatogastroenterology"},{"key":"508_CR17","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1111\/j.1572-0241.2007.01556.x","volume":"103","author":"J Langhorst","year":"2008","unstructured":"Langhorst J, Elsenbruch S, Koelzer J, Rueffer A, Michalsen A, Dobos GJ: Noninvasive markers in the assessment of intestinal inflammation in inflammatory bowel diseases: performance of fecal lactoferrin, calprotectin, and PMN-elastase, CRP, and clinical indices. Am J Gastroenterol. 2008, 103: 162-169.","journal-title":"Am J Gastroenterol"},{"key":"508_CR18","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1002\/ibd.20011","volume":"13","author":"A Ravi","year":"2007","unstructured":"Ravi A, Garg P, Sitaraman SV: Matrix metalloproteinases in inflammatory bowel disease: boon or a bane?. Inflamm Bowel Dis. 2007, 13: 97-107.","journal-title":"Inflamm Bowel Dis"},{"key":"508_CR19","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1007\/s00384-003-0495-y","volume":"18","author":"A Kapsoritakis","year":"2003","unstructured":"Kapsoritakis A, Sfiridaki A, Maltezos E, Simopoulos K, Giatromanolaki A, Sivridis E, Koukourakis MI: Vascular endothelial growth factor in inflammatory bowel disease. Int J Colorectal Dis. 2003, 18: 418-422.","journal-title":"Int J Colorectal Dis"},{"key":"508_CR20","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1136\/gut.2005.069476","volume":"55","author":"S Vermeire","year":"2006","unstructured":"Vermeire S, Van Assche G, Rutgeerts P: Laboratory markers in inflammatory bowel disease: useful, magic, or unnecessary toys?. Gut. 2006, 55: 426-431.","journal-title":"Gut"},{"key":"508_CR21","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1002\/ibd.20275","volume":"14","author":"AM Schoepfer","year":"2008","unstructured":"Schoepfer AM, Trummler M, Seeholzer P, Seibold-Schmid B, Seibold F: Discriminating IBD from IBS: comparison of the test performance of fecal markers, blood leucocytes, CRP, and IBD antibodies. Inflamm Bowel Dis. 2008, 14: 32-39.","journal-title":"Inflamm Bowel Dis"},{"key":"508_CR22","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1111\/j.1572-0241.2007.01126.x","volume":"102","author":"AC von Roon","year":"2007","unstructured":"von Roon AC, Karamountzos L, Purkayastha S, Reese GE, Darzi AW, Teare JP, Paraskeva P, Tekkis PP: Diagnostic precision of fecal calprotectin for inflammatory bowel disease and colorectal malignancy. Am J Gastroenterol. 2007, 102: 803-813.","journal-title":"Am J Gastroenterol"},{"key":"508_CR23","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.1007\/s10350-008-9310-8","volume":"51","author":"A Sutherland","year":"2008","unstructured":"Sutherland A, Gearry R, Frizelle F: Review of fecal biomarkers in inflammatory bowel disease. Dis Colon Rectum. 2008, 51: 1283-1291.","journal-title":"Dis Colon Rectum"},{"key":"508_CR24","doi-asserted-by":"crossref","first-page":"622","DOI":"10.20452\/pamw.506","volume":"118","author":"P Eder","year":"2008","unstructured":"Eder P, Stawczyk-Eder K, Krela-Ka\u017amierczak I, Linke K: Clinical utility of the assessment of fecal calprotectin in Le\u015bniowski-Crohn's disease. Pol Arch Med Wewn. 2008, 118: 622-626.","journal-title":"Pol Arch Med Wewn"},{"key":"508_CR25","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1515\/CCLM.2008.246","volume":"46","author":"CM Otten","year":"2008","unstructured":"Otten CM, Kok L, Witteman BJ, Baumgarten R, Kampman E, Moons KG, de Wit NJ: Diagnostic performance of rapid tests for detection of fecal calprotectin and lactoferrin and their ability to discriminate inflammatory from irritable bowel syndrome. Clin Chem Lab Med. 2008, 46: 1275-1280.","journal-title":"Clin Chem Lab Med"},{"key":"508_CR26","doi-asserted-by":"publisher","first-page":"1697","DOI":"10.1007\/s10350-007-0303-9","volume":"50","author":"AM Schoepfer","year":"2007","unstructured":"Schoepfer AM, Trummler M, Seeholzer P, Criblez DH, Seibold F: Accuracy of four fecal assays in the diagnosis of colitis. Dis Colon Rectum. 2007, 50: 1697-1706.","journal-title":"Dis Colon Rectum"},{"key":"508_CR27","doi-asserted-by":"publisher","first-page":"1394","DOI":"10.1136\/gut.2006.108043","volume":"56","author":"M Ferrante","year":"2007","unstructured":"Ferrante M, Henckaerts L, Joossens S, Pierik M, Joossens S, Dotan N, Norman GL, Altstock RT, Van Steen K, Rutgeerts P, Van Assche G, Vermeire S: New serological markers in inflammatory bowel disease are associated with complicated disease behavior. Gut. 2007, 56: 1394-1403.","journal-title":"Gut"},{"key":"508_CR28","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1002\/path.2394","volume":"216","author":"D Foell","year":"2008","unstructured":"Foell D, Wittkowski H, Ren Z, Turton J, Pang G, Daebritz J, Ehrchen J, Heidemann J, Borody T, Roth J, Clancy R: Phagocyte specific S100 proteins are released from affected mucosa and promote immune responses during inflammatory bowel disease. J Pathol. 2008, 216: 183-192.","journal-title":"J Pathol"},{"key":"508_CR29","doi-asserted-by":"publisher","first-page":"1462","DOI":"10.4065\/81.11.1462","volume":"81","author":"SS Mahid","year":"2006","unstructured":"Mahid SS, Minor KS, Soto RE, Hornung CA, Galandiuk S: Smoking and inflammatory bowel disease: a meta-analysis. Mayo Clin Proc. 2006, 81: 1462-1471.","journal-title":"Mayo Clin Proc"},{"key":"508_CR30","first-page":"403","volume":"43","author":"LG Jorgensen","year":"2005","unstructured":"Jorgensen LG, Fredholm L, Hyltoft Petersen P, Hey H, Munkholm P, Brandslund I: How accurate are clinical activity indices for scoring of disease activity in inflammatory bowel disease (IBD)?. Clin Chem Lab Med. 2005, 43: 403-411.","journal-title":"Clin Chem Lab Med"},{"key":"508_CR31","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1016\/j.cgh.2009.06.024","volume":"7","author":"D Turner","year":"2009","unstructured":"Turner D, Seow CH, Greenberg GR, Griffiths AM, Silverberg MS, Steinhart AH: A systematic prospective comparison of noninvasive disease activity indices in ulcerative colitis. Clin Gastroenterol Hepatol. 2009, 7: 1081-1088.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"508_CR32","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1111\/j.1365-3083.2006.01875.x","volume":"65","author":"A Larsen","year":"2007","unstructured":"Larsen A, Bronstein IB, Dahl O, Wentzel-Larsen T, Kristoffersen EK, Fagerhol MK: Quantification of S100A12 (EN-RAGE) in blood varies with sampling method, calcium and heparin. Scand J Immunol. 2007, 65: 192-201.","journal-title":"Scand J Immunol"}],"container-title":["BMC Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-230X-10-118.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-230X-10-118\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-230X-10-118","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-230X-10-118.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,26]],"date-time":"2025-02-26T20:30:34Z","timestamp":1740601834000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcgastroenterol.biomedcentral.com\/articles\/10.1186\/1471-230X-10-118"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,10,14]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,12]]}},"alternative-id":["508"],"URL":"https:\/\/doi.org\/10.1186\/1471-230x-10-118","relation":{},"ISSN":["1471-230X"],"issn-type":[{"value":"1471-230X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,10,14]]},"assertion":[{"value":"28 April 2010","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 October 2010","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 October 2010","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"118"}}